Active, not recruiting
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
NCT04517851
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States